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1. Introduction  
The biologically active form of vitamin D3, 1ǂ,25-dihydroxyvitamin D3 [1ǂ,25(OH)2D3], is 
formed through a multistep process in the liver and the kidneys, initiated in the skin by solar 
UVB radiation. Vitamin D compounds are transported in the body by vitamin D binding 
protein (DBP) to either nuclear vitamin D receptors (nVDR) or putative membrane associated 
vitamin D receptors (mVDR) where it exerts its biological responses in target organs by 
nuclear- and membrane- initiated signaling pathways (Bouillon et al., 1995; Holmén et al., 
2009). Finally, 1ǂ,25(OH)2D3 becomes inactivated by 24-hydroxylase which transforms it into 
1,24,25(OH)3D3, a substance with much lower affinity for VDR (Bouillon et al., 1995). 
In the nuclear initiated signaling pathway, occupancy of the nuclear vitamin D receptor 
(nVDR) by 1ǂ,25(OH)2D3 leads to modulation of gene transcription of hormone-sensitive 
genes (Krishnan & Feldman, 2010). In conformity with several other receptors of the nuclear 
steroid/thyroid superfamily, nVDR forms heterodimers with retinoid X receptor (RXR) 
(Sutton et al., 2003). Subsequent interaction with the vitamin D response element (VDRE) in 
the promoter sequence of target genes initiates induction or repression of transcription, 
hence generating a biological response (Haussler et al., 2011). 
Vitamin D exerts multiple actions in the organism including the well-known regulation of 
calcium and phosphate homeostasis (Holick, 2006), but it also possesses anti-proliferative, 
pro-differential and pro-apoptotic actions in cancer cells as well as increasing the effect of a 
number of established anti-cancer drugs (Trump et al., 2010). 
The association of vitamin D with human cancer is well described in adenocarcinoma of the 
prostate gland, i.e. prostate cancer (PCa). Clear correlation between vitamin D deficiency and 
risk factors for PCa, such as high age and darker pigmented skin, has been observed. Thus, the 
amount of vitamin D decline with age, and the elevated levels of melanin in African 
Americans partly inhibits sun initiated vitamin D synthesize (Hsing & Chokkaligam, 2006). 
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Furthermore, 1ǂ,25(OH)2D3 has been proven to decrease the risk of PCa by controlling prostate 
cell proliferation (Holick, 2006). 
In a previous paper, we have shown that 1ǂ,25(OH)2D3 regulates prostate cell 
differentiation, apoptosis and proliferation via multiple pathways, which involves both 
nuclear and membrane receptors found in the JNK/SAPK (c-Jun N-terminal kinases/stress-
activated protein kinase) pathway. (Hagberg et al., 2008; Larsson et al., 2008; Holmén et al., 
2009; Karlsson et al., 2010). 
The JNK/SAPK pathway may be induced by several different means, such as chemical and 
physical stress, UV-radiation and osmotic shock, as well as pro-inflammatory cytokines, and 
even G-coupled receptor signaling, (Matsukawa et al., 2004). Among the cytokines that triggers 
the JNK/SAPK pathway, TNF-ǂ is predominant, and it is also known to regulate cellular 
events associated with cancer cell phenotype, such as apoptosis, cell proliferation and 
differentiation. Still, it has been shown that cancer cells are resistant to apoptosis induced by 
TNF-ǂ (Chopra et al., 2004). This resistance seems to involve certain survival signals, one of 
which being the transcription factor, nuclear factor-kappa B (NF-κB). It is therefore thought 
that if NF-κB is inhibited, the cancer cells would become more sensitive to TNF-ǂ induced 
apoptosis. Indeed, this seemed to be the case in TNF-ǂ resistant leukemia cells that were 
treated with sulforaphane, a putative anti-cancer drug that showed a non-specific inhibition of 
the TNF-ǂ induced NF-κB activation (Moon et al., 2009). In addition, there were indications 
that this inhibition of NF-κB lead to prolonged JNK/SAPK activation in the leukemia cells. 
Other studies indicate that activation of JNK also seems to regulate and can be regulated by 
NF-κB (Nachmias et al., 2004). A similar result to the sulforaphane inhibition of the TNF- ǂ 
induced NF-κB has been reported for breast cancer cells treated with vitamin D. Thus, 
Michigan cancer foundation 7 (MCF-7) breast cancer cells, were found to become sensitized to 
apoptosis induced by TNF-ǂ when treated with 1ǂ,25(OH)2D3  (Golovko et al., 2005).  
Transcription factor NF-κB can be regulated in concert with another transcription factor, 
activator protein 1 (AP1). AP1 is a complex consisting of homodimers and heterodimers of 
the jun and fos families and the activity of AP1 seems to be regulated by differential 
expression of the jun and fos families. The c-Jun components of AP1 can be regulated by the 
phosphorylating activity of active JNK (Dedieu and Lefebvre, 2006). Thus, in the two 
prostate carcinoma cell lines PC-3 and LNCaP, overexpression of the early growth response 
protein EGR-1, selectively increased the activity of both NF-κB and AP1 and the activation 
of these transcription factors appeared to be essential for the induction of proliferation and 
anchorage independence (Parra et al., 2011). 
Another important mediator of cell proliferation, differentiation and apoptosis is the cyclic 
response element binding protein (CREB). CREB is part of the cAMP regulated pathway and 
is phosphorylated by protein kinase A (PKA). CREB does not have direct contact with the 
transcriptional machinery. Therefore it requires CREB binding protein (CBP) to achieve 
transcriptional activation. There are several steroid and thyroid hormones that act to bind 
CBP e.g. luteinizing hormone, glucagon and adrenaline which all exert influence over cAMP 
and PKA. There are no direct evidences that vitamin D receptors are coupled to a protein 
complex which includes adenylate cyclase. However, several studies have demonstrated 
that 1ǂ,25(OH)2D3 evoke rapid increases in PKA activity, intracellular cAMP concentrations 
which have been found to be associated with G-protein-coupled signaling as well as 
regulation of Ca2+ transport through Ca2+-channels (Massheimer et al., 1999; Schwartz et al., 
2002; Dirks-Naylor & Lennon-Edwards, 2011). 
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Knowing how the cell cycle arrest and the anti-proliferative effects are induced on a 
molecular level is important when developing successful therapeutic tools against cancer. 
1ǂ,25(OH)2D3 stands out as a potential anti-cancer drug, even with its severe side effect of 
hypercalcemia, and treating LNCaP cells with 1ǂ,25(OH)2D3 results in an accumulation of 
cells in the G1 phase, growth arrest, and to some extent apoptosis. In order to get a better 
understanding of how this kind of action of 1ǂ,25(OH)2D3 is regulated we have in this study 
made the following investigations:   
First, monitor the response on JNK/SAPK complex dependent activation of AP1 to 
1ǂ,25(OH)2D3 and TNF-ǂ in LNCaP prostate cancer cells. Secondly, decide whether 1 
ǂ,25(OH)2D3 regulates TNF-ǂ  production and release by LNCaP cells and thus have an 
indirect effect via the TNF-ǂ signaling pathway on cell growth, differentiation and 
apoptosis, and third, evaluate the PKA dependent activation of cyclic response element 
binding protein (CREB) in LNCaP cells treated with 1ǂ,25(OH)2D3. 
2. Materials and methods 
2.1 Cell culture 
LNCaP cells were cultured in Gibco RPMI 1640 media (Invitrogen, UK). The media 
contained FBS (10%), PEST (1%), L-glutamine (1%), HEPES and sodium pyruvate (1%). The 
cells were subcultured five days after the initial culture and seeded at a density of 20 000 
cells/well onto a 96-well plate (Nunc, Thermo Fischer Scientific, US) or 50 000 cells/well at a 
24 well plate (Nunc, Thermo Fisher Scientific). At the point of seeding to the plate, the 
growth media was substituted for Opti-MEM (Invitrogen, UK) with 5% FBS and 1% NEAA 
without phenol-red-free and without antibiotics to prepare for transfection. The cells were 
incubated at 37°C and 5% CO2 for 48 hour prior 1α,25(OH)2D3 treatment.   
2.2 Transient transfection and CREB reporter assay (cAMP/PKA)/AP1 reporter assay  
SureFECTTM transfection reagent and CignalTM CREB reporter/CignalTM AP1 reporter kit 
was used according to the manufacturer’s protocol (SA BioSciences, USA) to monitor 
cAMP/PKA pathway activity and the activity of AP1-regulated transduction pathways. The 
CREB reporter is a viral vector based on the Cytomegalo virus (CMV) that has been 
rendered replication incompetent and robbed of all virulence factors. It consist of inducible 
firefly luciferase that response to CREB and constitutively expressed Renilla constructs. The 
reporter is designed to monitor cAMP/PKA pathway activity and together with a Dual 
GloTM Luciferase Assay System (Promega, USA), it provides an easy approach to study the 
activity of this pathway.  The AP1 reporter contains a mixture of inducible AP1-responding 
firefly luciferase construct and a constitutively expressing Renilla luciferase construct. The 
luciferase construct codes for the firefly luciferase reporter gene which is under the control 
of a minimal cytomegalovirus (mCMV) promoter and tandem repeats of the TPA response 
element. The Renilla construct codes for the Renilla luciferase reporter gene, which acts 
under control of a CMV. It is used as a control for normalizing transfection efficiency and 
for monitoring cell viability. 
Briefly, in both assays, the LNCaP cells were transfected using SureENTRY transfection 
reagent in a 96-well plate. The LNCaP cells were seeded at the time of transfection. The 
medium used for the transfection was Opti-MEM serum-free culture medium. Dilutions of 
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the AP1/CREB reporter and the positive and negative controls were prepared as well as 
dilutions for SureENTRY. The cells were then washed with PBS and trypsinised and then 
suspended in Opti-MEM serum-free cell culture medium. The cell pellet was the 
resuspended in Opti-MEM cell culture medium. A haemocytometer was used to determine 
cell density and 10 000 cells was then seeded into each well. The Cignal reporter, negative 
and positive control was added to the appropriate wells and SureENTRY was added to each 
well and incubated for 48 hours. The cells were then treated with 1α,25(OH)2D3 and 
luminescence measurements were made for selected interval. 
2.3 1α,25(OH)2D3 and G-protein coupled PKA/CREB-dependent gene expression in  
LNCaP cells 
Following incubation, cells transfected with the CREB reporter, were treated with 
1α,25(OH)2D3 in the concentrations 10-7 M with or without the G-protein inhibitor 
Guanosine 5’-[β-thio]diphosphate trilithium (GDP-ǃ-S; 100 µM; Sigma-Aldrich). Ethanol 
(0,001%) was used as control.  
2.4 Luminescence measurements 
Luminescence levels were measured at four time points, 24, 48, 72 and 96h in a luminometer 
(FLUOstar Galaxy, BMG Labtech, Germany) using the Dual GloTM Luciferase Assay System 
(Promega, US). At the first interval, Dual Glo ReagentTM was prepared by mixing Dual Glo 
SubstrateTM with Dual Glo BufferTM at a ratio of 1:1. Stop & Glo ReagentTM was prepared by 
mixing Stop & Glo SubstrateTM with Stop & Glo BufferTM, at a ratio of 1:100 at each time 
interval, before measuring activity. At each measuring interval, 75 µl of Dual GloTM was 
added to the examined wells to check inducible activity, according to manufacturer’s 
recommendations and were incubated at room temperature for 12-15 minutes. Following 
the Firefly luciferase reading, 75 µl of Stop & Glo ReagentTM was added to check the non-
inducible luciferase activity. As with Dual Glo ReagentTM, the wells were incubated for 12-
15 minutes. The principle is that Firefly luciferase (Dual Glo ReagentTM) is inducible, while 
Renilla luciferase (Stop & Glo ReagentTM) is not. This provides a reference point to compare 
and normalize obtained data. 
2.5 Effects of 1α,25(OH)2D3 and TNF-α on AP1-dependent gene expression in  LNCaP 
cells 
The cells were treated with 1α,25(OH)2D3 (10-7 M) or TNF-α (10-9 M) with or without 20 µM 
SP600125 (JNK/SAPK inhibitor (0.001% of ethanol was used as a control)). Luminescence 
measurements were taken after 24, 48, 72 and 96h. The experiments were repeated in 
triplicates.  
2.6 Effects of 1α,25(OH)2D3 on TNF-α production in LNCaP cells  
Each well of a 24 well plate was seeded with 50 000 LNCaP cells. The cells were then treated 
with 10-7 M 1α,25(OH)2D3 and 20 µM of the JNK/SAPK inhibitor, SP600125. As a control, 
0.001% of ethanol was used. TNF-α production in the cell culture media was measured post 
72 and 96 hours treatment using a commercial TNF-α specific ELISAs according to the 
manufacturer’s instructions (Promega, USA). Each experiment was repeated three times. 
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2.7 Statistics 
Two-way ANOVAs were performed using GraphPad Prism to evaluate the data from the 
assays. For the AP1 reporter assay, triplicates were used for all four time points and all 
treatments except for the ethanol controls, in which case duplicates were used for all time 
points. For the TNF-α specific ELISA four replicates were used for all the samples and 
duplicates for the standards, control and blank wells. The P value threshold was set to 
0.05. 
3. Results and discussion 
Previous studies on prostate cancer cells have reported that 1α,25(OH)2D3 regulates 
proliferation and cell survival through membrane initiated signaling pathways (Hagberg 
et al., 2008; Larsson et al., 2008). Similar observations have been made in vitamin D 
responsive tissues, where membrane initiated signaling have been linked to PKA, PKC  
and MAPK signaling pathways (Schwartz et al., 2002; Dirks-Naylor and Lennon-Edwards, 
2011). This study was aimed to further elucidate membrane initiated signaling by 
1α,25(OH)2D3 in LNCaP prostate cancer cells by evaluating the effects of 1α,25(OH)2D3 on 
AP1 and CREB-dependent gene expression as well as testing the hypothesis that 
1α,25(OH)2D3 might evoke membrane initiated effects through TNF-α and TNF-α initiated 
signaling pathways. 
3.1 Effects of 1α,25(OH)2D3 on AP1-dependent gene expression 
As shown in Figure 1, 1α,25(OH)2D3 increased AP1-dependent gene expression after 
treatment at 48 (p<0.05), 72 (p<0.001) and 96h (p<0.0001) compared to control treated 
LNCaP cells (0.001% ethanol). The effect was time-dependent and at 96h, a difference in 
AP1-dependent gene expression was observed between the cells treated with 1α,25(OH)2D3 
and cells treated with 1α,25(OH)2D3 + SP600125 (JNK/SAPK inhibitor)(p<0.05). Thus, 
1α,25(OH)2D3 increase AP1-dependent gene expression through the JNK/SAPK signaling 
pathway in LNCaP prostate cancer cells. 
 
Fig. 1. Effects of 1 ǂ,25(OH)2D3 (10-7 M) on AP1-dependent gene expression. 
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AP1-dependent gene expression was determined in LNCaP prostate cancer cells by a AP1 
reporter assay (SA Biosciences) by measuring Firefly luciferase activity relative to the Renilla 
luciferase activity after treatment with 1 ǂ,25(OH)2D3 (10-7 M) with or without SP600125  
(20 µM), using ethanol as control. LNCaP cell were treated for 24, 48, 72 or 96h before 
measuring the AP1 activity. Data were normalised and are expressed as % of control. The 
level of significance was set to p<0,05. Data are presented as mean ± SEM 
The data from this study supports previous observations in prostate cancer cells where 
1α,25(OH)2D3 decrease cell proliferation (Larsson et al., 2008) and where at least a part of the 
decreased proliferation has been connected an increase in the phosphorylation of 
JNK/SAPK and c-jun (Larsson et al., 2008; Hagberg et al., 2008;  Karlsson et al., 2010). Effects 
on MAPK signaling pathways by 1α,25(OH)2D3 is not limited to prostate cancer cells. In 
human myeloid leukemia HL-60 cells, Kim et al. (2007) 1ǂ,25(OH)2D3 induced HL-60 cell 
differentiation through a pathway involved with PI3-K/PKC/ERK/JNK and in human 
osteosarcoma SaOS-2 cells (Wu et al., 2007), 1ǂ,25(OH)2D3 were reported to be involved in 
JNK/SAPK activation as well as ERK 1/2 MAPK signaling and that only sustained and not 
transient treatment with 1ǂ,25(OH)2D3 induced AP1 activation.  
3.2 Effects of TNF-α on AP1-dependent gene expression 
TNF-α increased AP1-dependent gene expression after 72 (p<0.01) and 96h (p<0.05) 
compared to control treated LNCaP cells. The effect was not time-dependent and no 
differences in AP1-dependent gene expression was observed between the cells treated with 
TNF-α and cells treated with TNF-α + SP600125 (JNK/SAPK inhibitor) at any time-point. 
Thus, TNF-α increases AP1-dependent gene expression in LNCaP prostate cancer cells. 
 
Fig. 2. Effects of TNF-α (1 nM) on AP1-dependent gene expression.  
AP1-dependent gene expression was determined in LNCaP prostate cancer cells by a AP1 
reporter assay (SA Biosciences) by measuring Firefly luciferase activity relative to the Renilla 
luciferase activity after treatment with TNF-α (1 nM) with or without SP600125 (20 µM), 
using ethanol as control. LNCaP cell were treated for 24, 48, 72 or 96h before measuring the 
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AP1 activity. Data were normalised and are expressed as % of control. The level of 
significance was set to p<0,05. Data are presented as mean ± SEM 
The findings in the present study are in concert with reports from MIN6N8 pancreatic β-
cells (Kim et al., 2005) and MCF7 breast cancer cells (Yin et al. 2009), where the JNK/SAPK 
signaling pathway was reported to increase AP1 dependent gene expression. However, Yin 
et al. (2009) showed that the AP1 transactivation activity had its peak after 3 hours but was 
still significantly elevated after 24h. In the present study, the response in an increased AP1 
activity came after 48 hours and persisted throughout the experiment. The difference in 
response reported in this study and by Yin et al. (2009) may be because of differences 
between breast cancer and prostate cancer cells but could also reflect that the concentration 
of TNF-α in experiments performed by Yin et al. (2009) could have been a limiting factor.  
3.3 Effects of 1α,25(OH)2D3 on TNF-α production in LNCaP cells and TNF-α 
concentrations in culture media  
The TNF-α specific ELISA showed that 1α,25(OH)2D3 did not affect the production of TNF-α 
in LNCaP cells and thus, does not have an effect on TNF-α signaling pathway by increased 
concentrations of the growth factor in the media. This suggest that TNF-α acts 
independently of 1α,25(OH)2D3 in activation of the JNK/SAPK signaling pathway. These 
results are consistent with the findings of Golovko et al. (2005), who reported that under 
physiological conditions, 1α,25(OH)2D3 does not affect the production of TNF-α, but that 
TNF-α mRNA expression was up-regulated by 1α,25(OH)2D3 as well as its analogue CB1093 
in LNCaP and PC3 prostate cancer cells. Chopra et al. (2004) studied the role of TNF-α in 
regulation of growth and apoptosis in three different prostate cell lines: normal prostate 
epithelial cells, LNCaP cells and PC3 cells and could demonstrate that normal prostate 
epithelial cells and PC3 cells were resistant to growth arrest and apoptosis induced by TNF-
α and LNCaP cells were highly sensitive to the growth factor. Thus, from the results in the 
present study as well as previous studies (Golovko et al., 2005; Chopra et al., 2004,) we 
conclude that 1α,25(OH)2D3 and TNF-α acts through independent pathways ending up in an 
up-regulation of AP1-dependent gene expression.  
3.4 Effects of 1α,25(OH)2D3 on CREB-dependent gene expression 
1α,25(OH)2D3 increased CREB-dependent gene expression compared to control treated 
LNCaP cells (Figure 3). The effect was time- and G protein-dependent where treatment with 
10-7 M 1α,25(OH)2D3 increased CREB-dependent gene expression compared to cells treated 
with 10-7 M 1α,25(OH)2D3 + GDP-β-s (G protein inhibitor ) at 24 (p<0.05), 48h (p<0.0001) but 
were decreased compared to the G-protein inhibited cells at 72h (p<0.05). Thus, 
1α,25(OH)2D3 increases CREB-dependent gene expression through a G protein-dependent  
PKA/CREB signaling pathway in LNCaP prostate cancer cells. 
PKA/CREB-dependent gene expression was determined in LNCaP prostate cancer cells by 
a CREB reporter assay (SA Biosciences) by measuring Firefly luciferase activity relative to 
the Renilla luciferase activity after treatment with 1ǂ,25(OH)2D3 (10-7 M) with or without 
GDP-β-S (100 µM), using ethanol as control. LNCaP cell were treated for 24, 48, 72 or 96h 
before measuring the CREB activity. Data were normalised and are expressed as % of 
control. The level of significance was set to p<0,05. Data are presented as mean ± SEM 
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Fig. 3. Effects of 1ǂ,25(OH)2D3 (10-7 M) on PKA/CREB-dependent gene expression.  
The fact that 1α,25(OH)2D3 both activate JNK/SAPK and PKA/CREB-dependent gene 
expression indicate that 1α,25(OH)2D3 exert it effects through more than one pathway and 
mean that there might be more than one receptor that mediate the responses of this 
metabolite. Alternatively, the receptor could form different complexes that upon activation 
start unique signal cascades. An example of a similar observation is membrane initiated 
signaling in skeletal muscle, where six different signaling pathways have been described for 
1α,25(OH)2D3 (Vasquez et al., 1996; Capiati et al., 2000; Dirks-Naylor and Lennon-Edwards, 
2011). The point that there are two different vitamin D receptors (VDR, PDIA3) associated 
with the cell membrane (Holmen et al., 2009; Karlsson et al., 2010) and that PDIA3 has been 
suggested to form a trimer with at least three high affinity binding sites (Karlsson et al., 
2010) make us to postulate that depending on the docking site of 1α,25(OH)2D3 to the 
receptor, the resulting change in three dimensional structure of the hormone-receptor 
complex, starts a subsequent signaling cascade. The response will thus be dependent on 
both time and space where both short-term and long-term effect will be important in 
regulating prostate cell biology. 
3.5 Conclusions 
In conclusion, our findings support previous reports and suggest that 1ǂ,25(OH)2D3 
regulate prostate cell biology via multiple pathways and targeting of specific pathways for 
1ǂ,25(OH)2D3 might provide more effective therapies compared to the vitamin D therapies 
currently clinically tested and may serve as a complementary treatment in patients with 
androgen independent prostate cancer. 
3.6 Future directives 
The nature of membrane initiated signaling as a response to 1α,25(OH)2D3 is not yet 
clarified. It has been debated over the last two decades and currently there are two major 
candidates to be a membrane associated receptor for 1α,25(OH)2D3 (VDR and PDIA3). Our 
laboratory have for several years studied membrane initiated signaling by 1α,25(OH)2D3, in 
silico and in vitro, to elucidate signaling pathways and its key components with the goal to 
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clarify the biological role of the pathways in regulating prostate cancer. Focus on future 
work will be to create specific antagonists and agonists (the pharmacopore approach) to the 
putative membrane associated receptors to clarify their functions in vitro and hopefully get 
molecules that have a high specificity to single receptor binding site. 
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